ANGIODYNAMICS INC (ANGO) Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD 2020 - 2024
Historical data
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
-
Summary
-
Angiodynamics Inc quarterly/annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest history and growth rate from 2020 to 2024.
- Angiodynamics Inc Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the quarter ending February 29, 2024 was -$200 M, a 1967% decline year-over-year.
- Angiodynamics Inc Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the twelve months ending February 29, 2024 was -$199 M, a 407% decline year-over-year.
- Angiodynamics Inc annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2022 was -$54.4 M, a 81.8% decline from 2021.
- Angiodynamics Inc annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2021 was -$29.9 M, a 16.9% increase from 2020.
- Angiodynamics Inc annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2020 was -$36.1 M, a 78.6% increase from 2019.
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Trailing 12 Months (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Quarterly (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, YoY Quarterly Growth (%)